Pfizer | 8-K: Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance
Pfizer | 8-K:Financial Results for the Third Quarter of 2024
Pfizer | 8-K: Tim Buckley Elected to Pfizer's Board of Directors
Pfizer | 8-K: Pfizer's Financial Results for the Second Quarter of 2024
Pfizer | 8-K: Important Information Regarding Long-Term Incentive (TSRUs)
Pfizer | 8-K: Pfizer Announced That It Is Beginning the Process of Finding a Successor for Dr. Mikael Dolsten
Pfizer | 8-K: Cyrus Taraporevala Elected to Pfizer's Board of Directors
Pfizer | 8-K: Current report
Pfizer | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pfizer | 8-K: Pfizer Reports First-Quarter 2024 Results
Pfizer | 8-K: Poll Results of Pfizer Meeting
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEFA14A: Others
Pfizer | DEF 14A: Definitive information statements
Pfizer | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data